XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Treasury [Member]
Additional Paid In Capital [Member]
Retained Earnings [Member]
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (790,000)    
Common stock, shares, outstanding at Dec. 31, 2018   79,004,000      
Beginning Balance, value at Dec. 31, 2018 $ 165,058 $ 7,900 $ (4,965) $ 550,548 $ (388,425)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (15,115)       (15,115)
Purchase of treasury stock, shares     (84,000)    
Purchase of treasury stock, value (120)   $ (120)    
Equity awards vested or exercised, shares   326,000      
Equity awards vested or exercised, value   $ 33   (33)  
Stock-based compensation expense 867     867  
Common stock, shares, outstanding at Mar. 31, 2019   79,330,000      
Ending Balance, value at Mar. 31, 2019 150,967 $ 7,933 (5,085) 551,382 (403,263)
Common stock, shares, outstanding at Dec. 31, 2018   79,004,000      
Beginning Balance, value at Dec. 31, 2018 165,058 $ 7,900 (4,965) 550,548 (388,425)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (54,075)        
Common stock, shares, outstanding at Sep. 30, 2019   80,078,000      
Ending Balance, value at Sep. 30, 2019 113,148 $ 8,008 $ (5,090) 552,453 (442,223)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (874,000)    
Cumulative-effect adjustment due to adoption of ASC Topic 842 | Accounting Standards Update 2016-02 [Member] 277       277
Common stock, shares, outstanding at Mar. 31, 2019   79,330,000      
Beginning Balance, value at Mar. 31, 2019 150,967 $ 7,933 $ (5,085) 551,382 (403,263)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (12,944)       (12,944)
Purchase of treasury stock, shares     (3,000)    
Purchase of treasury stock, value (5)   $ (5)    
Equity awards vested or exercised, shares   667,000      
Equity awards vested or exercised, value   $ 67   (67)  
Stock-based compensation expense 327     327  
Common stock, shares, outstanding at Jun. 30, 2019   79,997,000      
Ending Balance, value at Jun. 30, 2019 138,345 $ 8,000 $ (5,090) 551,642 (416,207)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (877,000)    
Net income (loss) (26,016)       (26,016)
Equity awards vested or exercised, shares   81,000      
Equity awards vested or exercised, value   $ 8   (8)  
Stock-based compensation expense 819     819  
Common stock, shares, outstanding at Sep. 30, 2019   80,078,000      
Ending Balance, value at Sep. 30, 2019 113,148 $ 8,008 $ (5,090) 552,453 (442,223)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (877,000)    
Treasury Stock, Shares     (877,000)    
Common stock, shares, outstanding at Dec. 31, 2019   80,079,000      
Beginning Balance, value at Dec. 31, 2019 104,076 $ 8,008 $ (5,090) 553,210 (452,052)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (69,104)       (69,104)
Purchase of treasury stock, shares     (165,000)    
Purchase of treasury stock, value (7)   $ (7)    
Equity awards vested or exercised, shares   542,000      
Equity awards vested or exercised, value   $ 54   (54)  
Stock-based compensation expense 328     328  
Common stock, shares, outstanding at Mar. 31, 2020   80,621,000      
Ending Balance, value at Mar. 31, 2020 35,293 $ 8,062 (5,097) 553,484 (521,156)
Common stock, shares, outstanding at Dec. 31, 2019   80,079,000      
Beginning Balance, value at Dec. 31, 2019 104,076 $ 8,008 (5,090) 553,210 (452,052)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (104,225)        
Common stock, shares, outstanding at May. 31, 2020   0      
Ending Balance, value at May. 31, 2020 0 $ 0 $ 0 0 0
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (1,042,000)    
Common stock, shares, outstanding at Mar. 31, 2020   80,621,000      
Beginning Balance, value at Mar. 31, 2020 35,293 $ 8,062 $ (5,097) 553,484 (521,156)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (35,121)       (35,121)
Purchase of treasury stock, shares     (100,000)    
Purchase of treasury stock, value (1)   $ (1)    
Equity awards vested or exercised, shares   363,000      
Equity awards vested or exercised, value   $ 36   (36)  
Equity awards vested in connection with the Plan, shares   7,946,000      
Equity awards vested in connection with the Plan, value   $ 795   (795)  
Stock-based compensation expense 978     978  
Common stock, shares, outstanding at May. 31, 2020   0      
Ending Balance, value at May. 31, 2020 0 $ 0 $ 0 0 0
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     0    
Issuance of Successor common stock to Prepetition Senior notes creditors and prior equity holders       18,083  
Net income (loss) (9,817)       (9,817)
Purchase of treasury stock, shares     (1,000)    
Common stock, shares, outstanding at Jun. 30, 2020   1,050,000      
Ending Balance, value at Jun. 30, 2020 129,142 $ 1 $ 0 138,958 (9,817)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Stock Issued During Period, Shares, New Issues   1,050,000      
Stock Issued During Period, Value, New Issues 18,084 $ 1      
Equity component of Convertible Notes, net of offering costs 120,875     120,875  
Common stock, shares, outstanding at May. 31, 2020   0      
Beginning Balance, value at May. 31, 2020 0 $ 0 0 0 0
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) $ (29,887)        
Common stock, shares, outstanding at Sep. 30, 2020 1,138,185 1,140,000      
Ending Balance, value at Sep. 30, 2020 $ 110,045 $ 1 $ 0 139,931 (29,887)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (1,000)    
Common stock, shares, outstanding at Jun. 30, 2020   1,050,000      
Beginning Balance, value at Jun. 30, 2020 129,142 $ 1 $ 0 138,958 (9,817)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Net income (loss) (20,070)       (20,070)
Equity awards vested or exercised, shares   90,000      
Stock-based compensation expense $ 973     973  
Common stock, shares, outstanding at Sep. 30, 2020 1,138,185 1,140,000      
Ending Balance, value at Sep. 30, 2020 $ 110,045 $ 1 $ 0 $ 139,931 $ (29,887)
Increase (Decrease) in Shareholders' Equity [Roll Forward]          
Treasury Stock, Shares     (1,000)